(株)ティムス · Pharmaceutical · FY ends Dec
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 大和日台バイオベンチャー投資事業有限責任組合 | 4,107,920 | 9.03% | — | — |
| 2 | THVP-1号投資事業有限責任組合 | 2,845,860 | 6.25% | — | — |
| 3 | 株式会社新日本科学 | 1,433,320 | 3.15% | — | — |
| 4 | 楽天証券株式会社 | 1,320,900 | 2.90% | — | — |
| 5 | 株式会社SBI証券 | 1,268,401 | 2.78% | — | — |
| 6 | 山本 哲郎 | 975,000 | 2.14% | — | — |
| 7 | 蓮見 惠司 | 804,000 | 1.76% | — | — |
| 8 | 富永 隆寛 | 700,000 | 1.53% | — | — |
| 9 | ニッセイ・キャピタル9号投資事業有限責任組合 | 664,380 | 1.46% | — | — |
| 10 | BNY GCM CLIENT ACCOUNT JPRD AC ISG | 539,800 | 1.18% | — | — |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 若林 拓朗 | President & Representative Director | 13,900 | — | — |
| 蓮見 惠司 | Chairman of the Board | 804,000 | — | — |
| 伊藤 剛 | Director | 20,000 | — | — |
| 横田 尚久 | Director | — | — | — |
| 髙梨 健 | Director | — | — | — |
| 並川 玲子 | Director | — | — | — |
| 小林 伸明 | Full-time Audit & Supervisory Board Member | — | — | — |
| 本田 一男 | Audit & Supervisory Board Member | — | — | — |
| 中村 健一 | Audit & Supervisory Board Member | 10,000 | — | — |
| 長谷川 紘之 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Dec 2025 | — | ¥-16.08 | — | — | 45,485,767 |
| FY ending Feb 2025 | — | ¥-16.38 | — | — | 40,330,067 |
| FY ending Feb 2024 | — | ¥-26.02 | — | — | 40,304,367 |
| FY ending Feb 2023 | — | ¥-25.28 | — | — | 36,574,880 |